Impact of SLCO1B1 and APOE gene polymorphisms on statin selection and prognosis in patients after percutaneous coronary intervention
Medical Journal of Chinese People′s Liberation ArmyVol. 50, Issue 10, Pages: 1298-1305(2025)
Clinical Research|更新时间:2025-11-05
分享给微信好友或者朋友圈
导出参考文献
Impact of SLCO1B1 and APOE gene polymorphisms on statin selection and prognosis in patients after percutaneous coronary intervention
增强出版
“The latest research has found that personalized statin therapy based on SLCO1B1 and APOE gene polymorphism detection can improve the blood lipid compliance rate, shorten the compliance time, and improve the prognosis of patients after PCI.”
作者机构:
1.天津市北辰医院心内科,天津 300400
2.天津市北辰医院心内功能室,天津 300400
作者简介:
E-mail: johnbikzly@163.com
基金信息:
the District-Level Scientific Research Project of Tianjin Beichen Hospital(SHGY-2021017)
Zheng Mei-Hua,Wang Rong-Rong,Qi Jie,et al.Impact of SLCO1B1 and APOE gene polymorphisms on statin selection and prognosis in patients after percutaneous coronary intervention[J].Medical Journal of Chinese People′s Liberation Army,2025,50(10):1298-1305.
Zheng Mei-Hua,Wang Rong-Rong,Qi Jie,et al.Impact of SLCO1B1 and APOE gene polymorphisms on statin selection and prognosis in patients after percutaneous coronary intervention[J].Medical Journal of Chinese People′s Liberation Army,2025,50(10):1298-1305. DOI: 10.11855/j.issn.0577-7402.0025.2025.0805.
Impact of SLCO1B1 and APOE gene polymorphisms on statin selection and prognosis in patients after percutaneous coronary intervention增强出版